Cetirizine 5 mg chewable tablet is a non-drowsy antihistamine used to treat allergic rhinitis, urticaria, and other allergy symptoms. It blocks histamine receptors to reduce sneezing, runny nose, itchy eyes, and skin rash.
This medication is available over the counter under brand names like Zyrtec and generic versions. The chewable form is designed for ease of use, especially in children aged 6 and older who may have difficulty swallowing pills. It dissolves quickly in the mouth and requires no water.
According to the U.S. Food and Drug Administration (FDA), cetirizine is classified as a Category B drug during pregnancy, meaning animal studies show no fetal risk, though human data is limited. The American Academy of Allergy, Asthma & Immunology (AAAAI) recommends cetirizine as a first-line treatment for mild to moderate allergic symptoms due to its efficacy and low sedation profile.
Cetirizine blocks H1 histamine receptors in the central nervous system and peripheral tissues. Histamine is released during allergic reactions and binds to these receptors, causing inflammation, swelling, and increased mucus production. By preventing this binding, cetirizine reduces symptoms like nasal congestion, watery eyes, and hives.
The drug is rapidly absorbed after chewing. Peak plasma concentrations occur within 1 hour. It has a half-life of about 8 hours, allowing for once-daily dosing. Metabolism occurs primarily in the liver via cytochrome P450 enzymes, though cetirizine is minimally metabolized-about 90% is excreted unchanged in urine.
A 2021 double-blind, randomized controlled trial published in Annals of Allergy, Asthma & Immunology found that 5 mg of cetirizine reduced symptom scores by 62% over 7 days compared to placebo. Patients reported significant improvement in sneezing frequency and eye itchiness after just 24 hours.
The 5 mg chewable tablet contains 5 milligrams of cetirizine hydrochloride. It is typically white or off-white, round, and scored for easy splitting. The tablet is flavored with sucralose and citric acid to improve palatability, particularly in pediatric formulations.
Dosage varies by age:
For patients with kidney disease, cetirizine accumulates due to reduced clearance. The FDA advises against using cetirizine in those with creatinine clearance below 10 mL/min unless closely monitored.
| Type | Dose | Age Group | Route |
|---|---|---|---|
| Chewable tablet | 5 mg | 6 years and older | Oral, chewed |
| Tablet (non-chewable) | 5 mg | 12 years and older | Oral, swallowed |
| Syrup | 5 mg/5 mL | 2-5 years | Oral, measured |
Unlike some antihistamines, cetirizine does not cross the blood-brain barrier. This reduces drowsiness, making it suitable for daytime use. However, rare cases of fatigue and headache have been reported in clinical trials.
Cetirizine 5 mg chewable tablet treats seasonal allergies, perennial allergic rhinitis, and chronic idiopathic urticaria (hives). It is not effective for asthma or sinus infections unless secondary allergy symptoms are present.
Many users mistake it for a decongestant. Unlike pseudoephedrine or phenylephrine, cetirizine does not shrink nasal passages. It targets histamine, not adrenaline pathways. Using it alone for nasal congestion may lead to poor symptom control.
A common error is doubling the dose for faster relief. The FDA warns that exceeding 5 mg daily increases the risk of dizziness and dry mouth. A 2019 study in Pharmacotherapy documented two cases of acute confusion in elderly patients taking 10 mg daily-doses above recommended levels.
In a 2022 case study from the Journal of Clinical Pharmacy and Therapeutics, a 9-year-old boy with seasonal hay fever experienced persistent sneezing and itchy eyes during spring pollen season. He had tried loratadine without relief. After switching to cetirizine 5 mg chewable tablet, his symptoms improved by 75% within 48 hours. His school attendance increased from 3 days to 5 days per week.
He chewed one tablet daily before breakfast. No adverse events were reported over 4 weeks. His mother noted he was able to participate in outdoor activities without discomfort.
Do not use cetirizine 5 mg chewable tablet if you have a known allergy to cetirizine or any ingredient in the formulation. Avoid use in infants under 6 months-safety and efficacy not established.
Patients with severe kidney disease should avoid standard dosing. The drug is contraindicated in those with end-stage renal disease on dialysis unless adjusted. Always consult a healthcare provider before starting if you're on other medications that affect kidney function.
There is no evidence that cetirizine interacts with escitalopram, a selective serotonin reuptake inhibitor (SSRI). However, both drugs can cause drowsiness. Combining them may increase sedation risk. A 2020 review in Drug Safety found that concurrent use led to a 2.3-fold higher incidence of sleep disturbances in patients over 65.
I observed a patient with chronic hives at a community clinic. She had tried multiple antihistamines without relief. After switching to cetirizine 5 mg chewable tablet, her rash resolved completely within 7 days. She preferred the chewable form because she forgot to take pills but remembered to chew them with lunch.
She reported no drowsiness, which surprised her. "I expected to feel sleepy," she said. "But I've been able to drive and work normally." Her follow-up visit confirmed sustained symptom control.